Health
Baricitinib treatment linked to reduced mortality in COVID-19 patients – Medical Xpress
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research…
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research by an international team coordinated by researchers from Karolinska Institutet in Sweden. The findings, published in the journal Science Advances, support the continuation of ongoing randomized clinical trials.
“We are pleased to report a 71 percent reduction in mortality for the group receiving baricitinib in addition to standard…
-
Noosa News19 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business19 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News19 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business23 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?